Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001140361-25-040220
Filing Date
2025-11-03
Accepted
2025-11-03 17:17:44
Documents
18
Period of Report
2025-10-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A ef20058178_8ka.htm   iXBRL 8-K/A 28462
2 EXHIBIT 10.1 ef20058178_ex10-1.htm EX-10.1 109680
6 image0.jpg GRAPHIC 314820
7 image1.jpg GRAPHIC 317814
8 image2.jpg GRAPHIC 337984
9 image3.jpg GRAPHIC 379089
10 image4.jpg GRAPHIC 152226
  Complete submission text file 0001140361-25-040220.txt   2357469

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20251028.xsd EX-101.SCH 3857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20251028_lab.xml EX-101.LAB 21967
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20251028_pre.xml EX-101.PRE 16039
20 EXTRACTED XBRL INSTANCE DOCUMENT ef20058178_8ka_htm.xml XML 4074
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19125 | Film No.: 251445232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)